Form 4: Rockwell Medical SVP, Chief Commercial Officer Timothy Chole Sells Shares Under 10b5-1 Plan

Timothy Chole, SVP, Chief Commercial Officer of Rockwell Medical, sold 1,001 shares of common stock at an average price of $2.05 on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On January 2, 2025, Timothy Chole, the SVP, Chief Commercial Officer of Rockwell Medical, sold 1,001 shares of the company's common stock.
• The sale was executed at a weighted average price of $2.05 per share, with individual prices ranging from $2.0401 to $2.0519.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on June 7, 2024.
• Following the transaction, Chole directly owns 54,170 shares of Rockwell Medical common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.

Industry Context

Sales by company insiders are a common occurrence and are often pre-planned through Rule 10b5-1 trading plans to avoid accusations of trading on material non-public information. The market typically views such sales in the context of the individual's overall holdings and the reasons behind the sale, which are not always disclosed.

Stakeholder Impact

• The sale of shares by an officer could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.

Key Dates